How much has BigHat Biosciences raised?

BigHat raised $19M Series A in 2021, $75M Series B in 2022 bringing company-reported funding to $100M, and CB Insights reports a $45M Series B-II in April 2025. The total shown here reflects disclosed public sources and avoids undisclosed internal or secondary figures.

Andreessen Horowitz provenance is included where public. Other investors and strategic backers are listed only when named in the cited public sources.

The latest valuation signal is: Private; valuation not publicly disclosed. If no current valuation is public, seller teams should use stage, hiring, product momentum, and funding recency instead of a made-up number.

Profitability is not publicly disclosed unless the company is public. No IPO timing is assumed without a company filing or announcement.

For sellers, the capital signal points to budget around the current strategic priorities: product scale, compliance, security, infrastructure, data, operations, and go-to-market execution.